Find the latest news from Novozymes' news archive.
20 April 2016
Q1 sales growth as expected; 2016 full-year organic sales growth and net profit outlook maintained
01 April 2016
Novozymes hereby announces that Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford Overseas Limited, now holds 5.04% of the B shares in Novozymes
31 March 2016
Novozymes Saphera® enables new innovation in lactose-free, fermented dairy products.
30 March 2016
With reference to company announcement no. 8/2016, a reduction of the company’s B common stock by DKK 6,000,000 via cancellation of 3,000,000 treasury B stocks, was adopted at
Novozymes A/S’ Annual Shareholders’ Meeting on February 24, 2016.
29 March 2016
Novozymes hereby announces that Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford Overseas Limited, has decreased its holding of B shares in Novozymes.
24 February 2016
Today, Novozymes A/S held its Annual Shareholders’ Meeting. The following were decided:
12 February 2016
Novozymes informs that Eivind Kolding will not seek election to the Board of Directors at the upcoming annual shareholders’ meeting February 24, 2016, as otherwise announced in the notice to the annual shareholders’ meeting.
08 February 2016
Today, Novozymes announces the formation of three divisions: Household Care & Technical Industries, Agriculture & Bioenergy and Food & Beverages.
03 February 2016
Former Secretary General of NATO Anders Fogh Rasmussen and Novozymes’ CEO take steps to highlight Europe’s problematic addiction to oil – and what can be done about it
25 January 2016
The product Alterion is based on beneficial bacteria that improve feed utilization and provide a natural alternative to antibiotic growth promoters on poultry farms.
| Copyright © 2016 Novozymes. All Rights Reserved.